These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Greenhouse Gas Emissions from Respiratory Treatments: Results from the SABA CARBON International Study. Alzaabi A; Bell JP; Montero-Arias F; Price DB; Jackson DJ; Wang HC; Budgen N; Farouk H; Maslova E Adv Ther; 2023 Nov; 40(11):4836-4856. PubMed ID: 37684493 [TBL] [Abstract][Full Text] [Related]
6. Overprescription of short-acting β Al Zaabi A; Busaidi N; Al Mutairy S; Yorgancıoğlu A; Aksu K; Al-Jahdali H; Wali S; Elsayed M; Beekman MJ Expert Rev Respir Med; 2022 Jul; 16(7):833-847. PubMed ID: 35848074 [TBL] [Abstract][Full Text] [Related]
7. Prevalence of overuse of short-acting beta-2 agonists (SABA) and associated factors among patients with asthma in Germany. Worth H; Criée CP; Vogelmeier CF; Kardos P; Becker EM; Kostev K; Mokros I; Schneider A Respir Res; 2021 Apr; 22(1):108. PubMed ID: 33863317 [TBL] [Abstract][Full Text] [Related]
8. Short-acting β2-agonists over-prescription in patients with asthma: an Indian subset analysis of international SABINA III study. Modi M; Mody K; Jhawar P; Sharma L; Padukudru Anand M; Gowda G; Mendiratta M; Kumar S; Nayar S; Manchanda M; Kumari Badam A; Singh M; Siddiqui W; Beekman M J Asthma; 2023 Jul; 60(7):1347-1358. PubMed ID: 36519934 [TBL] [Abstract][Full Text] [Related]
10. Short-acting beta-2 agonist prescription patterns and clinical outcomes in Chinese patients with asthma: an observational study in mainland China for the SABINA programme. Bao W; Zhang Y; Hang J; Guo Y; Tang W; Yun C; Deng J; Jin M; Lai K; Yu H; Beekman M; Zhou X; Zhang M Ther Adv Respir Dis; 2022; 16():17534666221115054. PubMed ID: 36065527 [TBL] [Abstract][Full Text] [Related]
11. Over-prescription of short-acting β Alzaabi A; Al Busaidi N; Pradhan R; Shandy F; Ibrahim N; Ashtar M; Khudadah K; Hegazy K; Samir M; Negm M; Farouk H; Al Khalidi A; Beekman M Asthma Res Pract; 2022 Jul; 8(1):3. PubMed ID: 35799290 [TBL] [Abstract][Full Text] [Related]
14. SABA Overuse in Russia - Burden and Possible Causes: An Analysis of the Russian Population in the SABINA III (SABA use IN Asthma) Study. Avdeev S; Voznesenskiy N; Boldina M; Ignatova G; Kostina N; Kulbaisov A; Leshchenko I; Beekman MJHI J Asthma Allergy; 2022; 15():371-379. PubMed ID: 35368426 [TBL] [Abstract][Full Text] [Related]
17. Short-acting β Ban AY; Vengadasalam P; Taher SW; Mohd Zim MA; Sirol Aflah SS; Daut UN; Hyder Ali IA; Pereirasamy L; Omar A; Ibrahim A; Mohd Tarekh NA; Chan SK; Ali N; Mohd Isa NA; Hussain H; Abdul Karim N; Raja Gopal V; Chiam SY; Beekman MJHI Malays Fam Physician; 2023; 18():32. PubMed ID: 37292227 [TBL] [Abstract][Full Text] [Related]
18. SABINA: An Overview of Short-Acting β Janson C; Menzies-Gow A; Nan C; Nuevo J; Papi A; Quint JK; Quirce S; Vogelmeier CF Adv Ther; 2020 Mar; 37(3):1124-1135. PubMed ID: 31981105 [TBL] [Abstract][Full Text] [Related]
19. Predictors of excessive short-acting β Kupczyk M; Barg W; Bochenek G; Brożek G; D Browiecki P; Brzostek D; D Browski A; Dobek R; Gawlik R; Kucharczyk A; Kupryś-Lipińska I; Mastalerz-Migas A; Kowalski ML Postepy Dermatol Alergol; 2023 Dec; 40(6):790-797. PubMed ID: 38282873 [TBL] [Abstract][Full Text] [Related]
20. Short-acting β2-agonist prescriptions in patients with asthma: findings from the South Korean cohort of SABINA III. Yoo KH; Kim SH; Kim SH; Moon JY; Park HW; Chang YS; Beekman MJHI Korean J Intern Med; 2024 Jan; 39(1):123-136. PubMed ID: 38057957 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]